We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Interval Between the Time of Second PEG Dose and the Start of the Colonoscopy (TOSP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01286961
Recruitment Status : Completed
First Posted : February 1, 2011
Last Update Posted : October 5, 2011
Sponsor:
Information provided by (Responsible Party):
Eun Hee Seo, Inje University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
As the duration of the interval between the time of last preparation-agent dose and the start of the colonoscopy is increasing, the quality of bowel preparation will be worse.

Condition or disease Intervention/treatment
The Timing of Bowel Preparation in Outpatient Colonoscopy Drug: bowel preparation using split dose of polyethylene glycol

Detailed Description:
The aim of the present studies is to determine how the duration of the interval of the time of last preparation dose and the start of colonoscopy affects the quality of the bowel preparation and when the proper timing of the colonoscopy is after completion of last preparation regimen
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 360 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Interval Between the Time of Second PEG Dose and the Start of the Colonoscopy
Study Start Date : January 2011
Actual Primary Completion Date : July 2011
Actual Study Completion Date : September 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Colonoscopy

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
outpatient colonoscopy, bowel preparation, split dose PEG
adult outpatients who undergo colonoscopy
 Drug: bowel preparation using split dose of polyethylene glycol
polyethylene glycol, split dose(2L/2L), each dose for 1-2hours
Other Name: Colyte


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Quality of bowel preparation according to Ottawa scale [ Time Frame: 6 months ]
    The primary end point of the study was to assess the quality of bowel preparation according to the Ottawa scale, including cleanliness and fluid quantity.


Secondary Outcome Measures :
  1. Proper timing of colonoscopy [ Time Frame: 6 months ]
    The secondary end points was to determine the proper interval between the completion of spliting bowel preparation and the start of colonoscopy.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult outpatients who undergo colonoscopy
Criteria

Inclusion Criteria:

  • Adult outpatients(18-85 years of age) who undergo colonoscopy for screening, cancer surveillance or with gastrointestinal symptoms, other symptoms

Exclusion Criteria:

  • age under 18 years, pregnancy, breast feeding, prior history of surgical large bowel resection, severe renal failure (creatinine ≥ 3.0mg/dL (normal 0.8-1.4)), drug addiction or major psychiatric illness; allergy to PEG, refusal of consent to participate in the study.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01286961


Locations
Layout table for location information
Korea, Republic of
Haeundae Paik Hospital
Busan, Korea, Republic of, 612-030
Sponsors and Collaborators
Inje University
Investigators
Layout table for investigator information
Study Director: Tae Oh Kim, Ph.D. Inje University School of Medicine, Haeundae Paik Hospital, Internal Medicine
Principal Investigator: Eun Hee Seo, M.D. Inje University School of Medicine, Haeundae Paik Hospital, Internal Medicine
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Eun Hee Seo, fellow, Inje University
ClinicalTrials.gov Identifier: NCT01286961    
Other Study ID Numbers: HGI 2011-02
First Posted: February 1, 2011    Key Record Dates
Last Update Posted: October 5, 2011
Last Verified: October 2011
Keywords provided by Eun Hee Seo, Inje University:
Bowel preparation
Polyethylene glycols
Colonoscopy
Outpatient